Akshay Dhar resigns as MD/CEO; Rudra Shriram named new MD; Q1 profit dips

CEO resignedPromoter family joins the boardManagement Changes View source PDF Explain this filing

DSFCL · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

+0.4%Reaction day

₹25.14

prior close

₹25.01

announcement price

In-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used+0.1%+0.4% vs market

Specialty Chemicals peers, median of 94sector-0.2%+0.6% vs sector

On the reaction day the stock moved 0.4 pts more than Nifty Microcap 250 and 0.6 pts more than its Specialty Chemicals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

-0.0

10m

-0.0

15m

-0.0

30m

-0.0

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

+0.4+0.1+0.4-0.2+0.6

Next day

+1.4+0.2+1.2-1.1+2.6

+3.5+0.6+2.9-0.9+4.3

+5.5-0.0+5.5-1.2+6.7

+7.6+0.5+7.1-1.3+8.9

+9.8+0.8+9.0-1.0+10.8

+7.4+0.6+6.8-1.0+8.4

15d

+2.9+1.3+1.7+0.6+2.3

-2.3-1.4-0.9-1.9-0.4

+11.4-0.6+12.0-0.9+12.2

—————

UpDownMarket · Nifty Microcap 250Sector · Specialty Chemicals peers, median of 94Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Akshay Dhar resigned as MD and CEO effective Aug 14, 2026 to focus on new projects and expansion. Rudra Shriram, son of Chairman Alok B Shriram, appointed as new MD for 5 years from Aug 15. Rakesh Malhotra joins as Independent Director. Q1 FY27 standalone net profit fell to Rs 241.64 lakhs vs Rs 413.21 lakhs last year, on revenue of Rs 9,078 lakhs.

Likely market impact

Leadership change with promoter family taking helm; Q1 net profit fell 41% YoY. Watch for strategy continuity.